Preclinical and clinical studies have found cancer-associated fibroblast-derived IL-8 to increase PDAC invasiveness, while Fusobacterium nucleatum in the tumor microenvironment promotes IL-8 secretion and autocrine signaling in PDAC cells to boost invasion [49–51]. The gene discussed is CXCL8; the disease is neoplasm.